Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanoma
about
Melanoma: from melanocyte to genetic alterations and clinical optionsOptimized tumor cryptic peptides: the basis for universal neo-antigen-like tumor vaccinesTranslational implications of tumor heterogeneityShedding light on melanocyte pathobiology in vivoLeveraging fluorinated glucosamine action to boost antitumor immunityLarge molecular systems landscape uncovers T cell trapping in human skin cancer.Long Term Survival and Continued Complete Response of Vemurafenib in a Metastatic Melanoma Patient with BRAF V600K Mutation.The spectrum of resistance in SR/CR mice: the critical role of chemoattraction in the cancer/leukocyte interactionImmunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanomaThe clinical significance of tumor infiltrating lymphoctyes in breast cancer: does subtype matter?Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival.In vivo discovery of immunotherapy targets in the tumour microenvironment.Antibody therapies for melanoma: new and emerging opportunities to activate immunity (Review).Decreased intratumoral Foxp3 Tregs and increased dendritic cell density by neoadjuvant chemotherapy associated with favorable prognosis in advanced gastric cancerDifferential pattern and prognostic significance of CD4+, FOXP3+ and IL-17+ tumor infiltrating lymphocytes in ductal and lobular breast cancers.Pathway-based evaluation in early onset colorectal cancer suggests focal adhesion and immunosuppression along with epithelial-mesenchymal transition.Rab25 Small GTPase Mediates Secretion of Tumor Necrosis Factor Receptor Superfamily Member 11b (osteoprotegerin) Protecting Cancer Cells from Effects of TRAILMelanoma expression of matrix metalloproteinase-23 is associated with blunted tumor immunity and poor responses to immunotherapySuccessful treatment of metastatic melanoma by adoptive transfer of blood-derived polyclonal tumor-specific CD4+ and CD8+ T cells in combination with low-dose interferon-alpha.The two faces of interferon-γ in cancer.A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma.MPO density in primary cancer biopsies of ovarian carcinoma enhances the indicative value of IL-17 for chemosensitivity.Whole recombinant yeast vaccine induces antitumor immunity and improves survival in a genetically engineered mouse model of melanoma.Conservation of immune gene signatures in solid tumors and prognostic implications.High endothelial venules (HEVs) in human melanoma lesions: Major gateways for tumor-infiltrating lymphocytesIRF-8 controls melanoma progression by regulating the cross talk between cancer and immune cells within the tumor microenvironment.Defining lymphocyte-predominant breast cancer by the proportion of lymphocyte-rich stroma and its significance in routine histopathological diagnosisIncreased proportion of FoxP3+ regulatory T cells in tumor infiltrating lymphocytes is associated with tumor recurrence and reduced survival in patients with glioblastoma.Potentiation of immunomodulatory antibody therapy with oncolytic viruses for treatment of cancer.Connecting the Dots: Therapy-Induced Senescence and a Tumor-Suppressive Immune Microenvironment.CAR-T Cell Therapies From the Transfusion Medicine PerspectiveRegression of advanced melanoma upon withdrawal of immunosuppression: case series and literature review.High-throughput sequencing of T-cell receptors reveals a homogeneous repertoire of tumour-infiltrating lymphocytes in ovarian cancerTumor-infiltrating lymphocyte grade in primary melanomas is independently associated with melanoma-specific survival in the population-based genes, environment and melanoma study.Implications of corticotropin releasing factor in targeted anticancer therapy.Targeting human inducible regulatory T cells (Tr1) in patients with cancer: blocking of adenosine-prostaglandin E₂ cooperation.The role of the adenosinergic pathway in immunosuppression mediated by human regulatory T cells (Treg).T regulatory cells in B-cell malignancy - tumour support or kiss of death?What are regulatory T cells (Treg) regulating in cancer and why?Anti-cytotoxic T lymphocyte antigen-4 antibodies in melanoma.
P2860
Q21284811-1D9D8A30-7254-404C-96CF-0CDC73A62F83Q26738680-50E0704B-48EE-453A-8EFF-CDF2A0679674Q26822823-DC2DC25B-0E7B-4008-B1D7-40A958C51AB5Q26866190-07771D1F-1198-4CF4-BD15-3E09FDA4823DQ27008230-7C2AA835-E3EB-4F4E-9CEC-8865E4A00122Q27302197-2C601A00-0C17-4CBB-8B03-003DD00B2791Q27853361-FC330A02-2744-474F-9E47-43299071A8AFQ28972215-B5A952F7-030E-4928-8CA1-3429F3604AF5Q30422102-32933F83-5BD9-416B-A51C-BC7D8A0448E2Q31053828-4C92A078-510F-4A6E-B619-E6723FDA6664Q33564510-994D9F41-CCC8-4115-A4C4-A23F2E5F7846Q33736396-71B95738-CB44-4BF3-968C-29455C379CB0Q34000700-E27C31E0-B8FE-430B-8C1A-A2EA3D4E65D3Q34121330-17E2A53C-5ECE-405A-A041-87ACC04608EAQ34218825-EA04D393-1F50-4FD2-AFAC-B57E21B371F4Q34229772-D7293BD6-938B-4B59-8887-0184EB3443D9Q34700466-6F16A4FA-5503-4337-9410-A8FDEA38E6BEQ34748331-D59E0254-A575-4595-9A7E-E385BAB8122EQ35057739-CC89D84A-D7C1-4361-9AFE-272D92359413Q35269015-0FC1B83F-B8CA-4CC7-8F2F-054EB7A0B7FDQ35617517-39737856-64E8-4890-84F4-7A26B48CCD1CQ36105442-FA984A85-C6B8-470F-9208-41144CE79FB6Q36130491-6C47256C-1B24-47E9-B5D0-52883828438CQ36200301-0EBFDFBA-9AE5-48BB-BF10-C8D434263D23Q36373347-0682B4FB-574C-40F9-94D4-A5DE6D19EA0DQ36520732-82D6B46D-807E-4CEA-9C33-5E44F7BABC29Q36536652-1A0E0AC0-74EF-4F0E-BE52-906E1F466003Q36639475-F357176E-A544-4AB3-BAAE-9592DD84FB39Q36664213-56C37C4A-D642-46F3-B81A-FAB193985B0EQ36848064-5CCBBD61-BB6D-4F56-937A-A770F93053DDQ37022738-437539F3-D956-4BBE-9881-BC6CABEE389EQ37051177-E96F8455-40AC-44F3-8495-C1BA87734A24Q37233874-3D5DF44E-2B05-4739-AE74-BD35D2BD3584Q37289626-212D050E-59EF-4C00-8E25-944374A72072Q37867268-1986FA82-D691-4DF0-8152-C04AEED03DA2Q37894107-793AD85A-BC62-49E8-82DA-A04EC477B253Q37956691-80C71C2F-641A-4DD0-BF2D-8D4BC09C4383Q37960166-1C0D231A-4545-4A70-9358-90DB9B880CEEQ37998754-31C42243-287C-41A5-921A-A3545F67C71DQ38160837-CDE4698E-BDD7-476E-94CC-9F833EC0C12C
P2860
Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanoma
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Focus on TILs: prognostic sign ...... lymphocytes in human melanoma
@ast
Focus on TILs: prognostic sign ...... lymphocytes in human melanoma
@en
Focus on TILs: prognostic sign ...... lymphocytes in human melanoma
@nl
type
label
Focus on TILs: prognostic sign ...... lymphocytes in human melanoma
@ast
Focus on TILs: prognostic sign ...... lymphocytes in human melanoma
@en
Focus on TILs: prognostic sign ...... lymphocytes in human melanoma
@nl
prefLabel
Focus on TILs: prognostic sign ...... lymphocytes in human melanoma
@ast
Focus on TILs: prognostic sign ...... lymphocytes in human melanoma
@en
Focus on TILs: prognostic sign ...... lymphocytes in human melanoma
@nl
P2093
P2860
P1433
P1476
Focus on TILs: prognostic sign ...... lymphocytes in human melanoma
@en
P2093
Darryl A Oble
Martin C Mihm
Robert Loewe
P2860
P577
2009-04-02T00:00:00Z